البلد: أستراليا
اللغة: الإنجليزية
المصدر: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CLOXACILLIN AS THE BENZATHINE SALT
NORBROOK LABORATORIES AUSTRALIA PTY LIMITED
cloxacillin as benzathine(500mg/Sg)
MISC. INTRA MAMMARY
CLOXACILLIN AS THE BENZATHINE SALT ANTIBIOTIC Active 500.0 mg/4.5g
100 Syrs; 20 Syrs; 200 Syrs; 4.5g Syr
VM - Veterinary Medicine
DAIRY CATTLE | BOVINE | BREEDERS | CALVES | DAIRY COW | GROWERS | LACTATING COW | MILKING COW
ANTIBIOTIC & RELATED
MASTITIS | SUBCLINICAL MASTITIS
Poison schedule: 4; Withholding period: WHP: Milk: DO NOT USE in lactating cows or within 30 days of calving. After c alving colostrum or milk from treated dry cows MUST NOT BE USED for human con sumption or processing for 96 hours (8 milkings). If premature or unscheduled calving occurs consult the prescribing veterinarian for advice on handling mi lk for bobby calves. Meat: DO NOT USE l ess than 30 days before slaughter for h uman consumption.; Host/pest details: DAIRY CATTLE: [MASTITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: DAIRY CATTLE: [MASTITIS]; For the treatment of subclinical mastitis caused by organisms sensitive to cloxacillin in dairy cows at drying off.DO NOT USE in lactating cows or within 30 days of calving. DO NOT USE in cows allergic to penicillin
Registered
2023-07-01
APPROVED LABEL Info PEST Verified Draft Label Text: NOROCLOX 500 Dry Cow Intramammary Suspension Bucket: Main panel Text above the header line and below the footer line does not appear on the label PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY NOROCLOX 500 DRY COW INTRAMAMMARY SUSPENSION Each 4.5 g syringe contains 500 mg CLOXACILLIN (as benzathine salt) For the treatment of subclinical mastitis caused by organisms sensitive to cloxacillin in dairy cows at drying off. CONTENTS: 100X 4.5 G SYRINGES APPROVED LABEL Draft Label Text: NOROCLOX 500 Dry Cow Intramammary Suspension Bucket: Main panel Text above the header line and below the footer line does not appear on the label PRESENTATION NOROCLOX 500 is a stable intramammary suspension prepared under sterile conditions. Each single dose 4.5 g syringe contains 500 mg CLOXACILLIN (as the benzathine salt) in a long-acting base with 3% aluminium stearate. Benzathine cloxacillin is a semi-synthetic penicillin derived from 6-aminopenicillinic acid. USES NOROCLOX 500 is formulated for the treatment of subclinical mastitis caused by organisms sensitive to cloxacillin in dairy cows at drying off. NOROCLOX 500 is active against Gram positive organisms associated with mastitis and is effective against _Streptococcus _ _dysgalactiae_ and other streptococci and _Arcanobacterium pyogenes_. As cloxacillin is not destroyed by staphylococcal penicillinase, NOROCLOX 500 is active against penicillin- resistant staphylococci which are an important cause of bovine mastitis. NOROCLOX 500 contains benzathine cloxacillin in a long-acting aluminium stearate base. NOROCLOX 500 is bactericidal in action and is non-irritant in the اقرأ الوثيقة كاملة
PRODUCT NAME: NOROCLOX 500 DRY COW INTRAMAMMARY SUSPENSION PAGE: 1 OF 4 THIS REVISION ISSUED: SEPTEMBER, 2009 MATERIAL SAFETY DATA SHEET Issued by: Norbrook Laboratories Australia Pty Ltd Freecall: 1800 665 866 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY NORBROOK LABORATORIES AUSTRALIA PTY LTD FREECALL: 1800 665 866 UNIT 7/1 TRADE PARK DRIVE TULLAMARINE, VIC 3043 AUSTRALIA SUBSTANCE: Cloxacillin is semi-synthetic penicillin derived from 6-amino-penicillanic acid. TRADE NAME: NOROCLOX 500 DRY COW INTRAMAMMARY SUSPENSION APVMA CODE: 56978 PRODUCT USE: An intramammary suspension containing cloxacillin (as the benzathine salt) in a long acting base with aluminium stearate for the control of mastitis in dairy cows. CREATION DATE: SEPTEMBER, 2009 THIS VERSION ISSUED: SEPTEMBER, 2009 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR: Off-white to creamy liquid suspension. ODOUR: Virtually odourless. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. This is an antibiotic preparation. Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medi اقرأ الوثيقة كاملة